Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946060 | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y017062 | SC / LA |
Heplisav-B dose 2 of 2 and Varicella 2 of 2 given in clinic. 10 minutes post vaccination patient stated she began feeling a tingling sensation in her left arm where the varicella vaccine was given. She reports that it radiated from her shoulder down into her fingers. She reported to nurse that she felt her left hand was beginning to swell. Nurse observed petechiae around injection site 10 minutes post vaccination. Petechiae did not spread further then around injection site. Clinic provider ordered 25mg PO Benadryl STAT to be given, and ice pack applied to site. Patient rested in chair and was observed in clinic for 3 hours. Symptoms began improving 20 minutes after Benadryl was given. At the end of 3-hour observation period petechiae around injection site was minimal, patient reported itching sensation went from severe to mild, and patient reported the swelling sensation in her left hand decreased. No symptoms occurred in arm that Heplisav-B was given.
None
None
None
None
None